HCA Free cash flow | HCA Healthcare, Inc.

HCA Healthcare, Inc. (HCA) Free cash flow

Free cash flow · 12 months (USD): Value $7.93B; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-03-31..
Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-03-31..
Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-03-31..
Free cash flow margin · 12 months: Value 10.38%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-03-31..

Free cash flow

Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.

Metric	Value	Formula and calculation
Free cash flow · 12 months (USD)	$7.93B	Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-03-31. $13.00B − $5.07B ≈ $7.93B
Price / free cash flow · 12 months	(m)	Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m).
Free cash flow yield · 12 months	(m)	(Operating cash flow − capital spending) / current market cap. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m).
Free cash flow margin · 12 months	10.38%	(Operating cash flow − capital spending) / revenue. Period ending 2026-03-31. $7.93B ÷ $76.39B × 100 ≈ 10.38%
Free cash flow per share · 12 months	(m)	(Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m).
Operating cash flow · 12 months	$13.00B	Cash generated by operating activities. Period ending 2026-03-31.
Operating cash flow / net income · 12 months	1.91×	Operating cash flow / net income. Period ending 2026-03-31. $13.00B ÷ $6.79B ≈ 1.91×

Calculation inputs

Input	Amount with unit	Raw financial data
Operating cash flow	13.00B USD	Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Capital spending	5.07B USD	Payments to Acquire Property, Plant, and Equipment
Market cap	(m)
Free cash flow	7.93B USD	Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment
Revenue	76.39B USD
Quarter-end shares	(m)	Common Stock, Shares, Outstanding
Net income	6.79B USD	Net Income (Loss) Attributable to Parent

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period ending	Free cash flow	FCF per share	Operating cash flow	Capital spending (USD)	Market cap (USD)	Revenue (USD)	Quarter-end shares (shares)	Net income (USD)	Price / FCF	FCF yield	FCF margin	Cash conversion
2026-03-31	$7.93B	(m)	$13.00B	$5.07B	(m)	$76.39B	(m)	$6.79B	(m)	(m)	10.38%	1.91×
2025-12-31	$7.69B	(m)	$12.64B	$4.94B	(m)	$75.60B	(m)	$6.78B	(m)	(m)	10.17%	1.86×
2025-09-30	$8.10B	(m)	$12.84B	$4.74B	(m)	$74.37B	(m)	$6.34B	(m)	(m)	10.89%	2.02×
2025-06-30	$7.29B	(m)	$11.94B	$4.64B	(m)	$72.70B	(m)	$5.97B	(m)	(m)	10.03%	2.00×
2025-03-31	$4.95B	(m)	$9.70B	$4.75B	(m)	$71.58B	(m)	$5.78B	(m)	(m)	6.91%	1.68×
2024-12-31	$5.64B	(m)	$10.51B	$4.88B	(m)	$70.60B	(m)	$5.76B	(m)	(m)	7.99%	1.83×
2024-09-30	$5.88B	(m)	$10.63B	$4.75B	(m)	$69.62B	(m)	$5.93B	(m)	(m)	8.45%	1.79×
2024-06-30	$4.89B	(m)	$9.59B	$4.71B	(m)	$68.35B	(m)	$5.74B	(m)	(m)	7.15%	1.67×
2024-03-31	$5.43B	(m)	$10.10B	$4.67B	(m)	$66.72B	(m)	$5.47B	(m)	(m)	8.14%	1.85×
2023-12-31	$4.69B	(m)	$9.43B	$4.74B	(m)	$64.97B	(m)	$5.24B	(m)	(m)	7.21%	1.80×
2023-09-30	$4.38B	(m)	$9.28B	$4.91B	(m)	$63.16B	(m)	$5.72B	(m)	(m)	6.93%	1.62×
2023-06-30	$4.93B	(m)	$9.82B	$4.89B	(m)	$61.92B	(m)	$5.77B	(m)	(m)	7.97%	1.70×
2023-03-31	$4.25B	(m)	$8.98B	$4.73B	(m)	$60.88B	(m)	$5.73B	(m)	(m)	6.98%	1.57×
2022-12-31	$4.13B	(m)	$8.52B	$4.39B	(m)	$60.23B	(m)	$5.64B	(m)	(m)	6.85%	1.51×
2022-09-30	$4.17B	(m)	$8.44B	$4.26B	(m)	$59.80B	(m)	$5.38B	(m)	(m)	6.98%	1.57×
2022-06-30	$3.67B	(m)	$7.70B	$4.02B	(m)	$60.10B	(m)	$6.51B	(m)	(m)	6.11%	1.18×
2022-03-31	$4.53B	(m)	$8.32B	$3.78B	(m)	$59.72B	(m)	$6.81B	(m)	(m)	7.59%	1.22×
2021-12-31	$5.38B	(m)	$8.96B	$3.58B	(m)	$58.75B	(m)	$6.96B	(m)	(m)	9.16%	1.29×
2021-09-30	$-200.00M	(m)	$2.93B	$3.13B	(m)	(m)	(m)	$6.57B	(m)	(m)	(m)	0.45×
2021-06-30	$640.00M	(m)	$3.37B	$2.73B	(m)	(m)	(m)	$4.97B	(m)	(m)	(m)	0.68×
2021-03-31	$7.21B	(m)	$9.85B	$2.64B	(m)	(m)	(m)	$4.60B	(m)	(m)	(m)	2.14×
2020-12-31	$6.40B	(m)	$9.23B	$2.83B	(m)	(m)	(m)	$3.75B	(m)	(m)	(m)	2.46×
2020-09-30	$11.96B	(m)	$15.32B	$3.36B	(m)	(m)	(m)	$3.40B	(m)	(m)	(m)	4.51×
2020-06-30	$10.72B	(m)	$14.73B	$4.01B	(m)	(m)	(m)	$3.34B	(m)	(m)	(m)	4.41×
2020-03-31	$3.77B	(m)	$8.00B	$4.23B	(m)	(m)	(m)	$3.05B	(m)	(m)	(m)	2.63×
2019-12-31	$3.44B	(m)	$7.60B	$4.16B	(m)	(m)	(m)	$3.50B	(m)	(m)	(m)	2.17×
2019-09-30	$3.23B	(m)	$7.27B	$4.04B	(m)	(m)	(m)	$3.50B	(m)	(m)	(m)	2.08×
2019-06-30	$3.12B	(m)	$6.87B	$3.74B	(m)	(m)	(m)	$3.65B	(m)	(m)	(m)	1.88×
2019-03-31	$2.79B	(m)	$6.45B	$3.66B	(m)	(m)	(m)	$3.68B	(m)	(m)	(m)	1.75×
2018-12-31	$3.19B	(m)	$6.76B	$3.57B	(m)	(m)	(m)	$3.79B	(m)	(m)	(m)	1.79×
2018-09-30	$2.92B	(m)	$6.32B	$3.40B	(m)	(m)	(m)	$3.20B	(m)	(m)	(m)	1.98×
2018-06-30	$2.32B	(m)	$5.61B	$3.29B	(m)	(m)	(m)	$2.86B	(m)	(m)	(m)	1.96×
2018-03-31	$2.31B	(m)	$5.45B	$3.14B	(m)	(m)	(m)	$2.70B	(m)	(m)	(m)	2.02×
2017-12-31	$2.41B	(m)	$5.43B	$3.02B	(m)	(m)	(m)	$2.22B	(m)	(m)	(m)	2.45×
2017-09-30	$2.48B	(m)	$5.39B	$2.91B	(m)	(m)	(m)	$2.66B	(m)	(m)	(m)	2.03×
2017-06-30	$2.70B	(m)	$5.59B	$2.89B	(m)	(m)	(m)	$2.85B	(m)	(m)	(m)	1.96×
2017-03-31	$2.71B	(m)	$5.53B	$2.82B	(m)	(m)	(m)	$2.85B	(m)	(m)	(m)	1.94×
2016-12-31	$2.89B	(m)	$5.65B	$2.76B	(m)	(m)	(m)	$2.89B	(m)	(m)	(m)	1.96×
2016-09-30	$2.82B	(m)	$5.51B	$2.69B	(m)	(m)	(m)	$2.55B	(m)	(m)	(m)	2.16×
2016-06-30	$2.86B	(m)	$5.41B	$2.54B	(m)	(m)	(m)	$2.38B	(m)	(m)	(m)	2.27×
2016-03-31	$2.68B	(m)	$5.12B	$2.44B	(m)	(m)	(m)	$2.23B	(m)	(m)	(m)	2.29×
2015-12-31	$2.36B	(m)	$4.73B	$2.38B	(m)	(m)	(m)	$2.13B	(m)	(m)	(m)	2.22×
2015-09-30	$2.54B	(m)	$4.80B	$2.27B	(m)	(m)	(m)	$2.07B	(m)	(m)	(m)	2.32×
2015-06-30	$2.56B	(m)	$4.83B	$2.27B	(m)	(m)	(m)	$2.14B	(m)	(m)	(m)	2.25×
2015-03-31	$2.80B	(m)	$5.02B	$2.22B	(m)	(m)	(m)	$2.12B	(m)	(m)	(m)	2.37×
2014-12-31	$2.27B	(m)	$4.45B	$2.18B	(m)	(m)	(m)	$1.88B	(m)	(m)	(m)	2.37×
2014-09-30	$1.97B	(m)	$4.05B	$2.08B	(m)	(m)	(m)	$1.77B	(m)	(m)	(m)	2.28×
2014-06-30	$1.86B	(m)	$3.82B	$1.96B	(m)	(m)	(m)	$1.62B	(m)	(m)	(m)	2.36×
2014-03-31	$1.44B	(m)	$3.38B	$1.94B	(m)	(m)	(m)	$1.56B	(m)	(m)	(m)	2.17×
2013-12-31	$1.74B	(m)	$3.68B	$1.94B	(m)	(m)	(m)	$1.56B	(m)	(m)	(m)	2.37×
2013-09-30	$1.78B	(m)	$3.72B	$1.94B	(m)	(m)	(m)	$1.45B	(m)	(m)	(m)	2.57×
2013-06-30	$1.50B	(m)	$3.47B	$1.97B	(m)	(m)	(m)	$1.44B	(m)	(m)	(m)	2.41×
2013-03-31	$2.19B	(m)	$4.12B	$1.93B	(m)	(m)	(m)	$1.41B	(m)	(m)	(m)	2.92×
2012-12-31	$2.31B	(m)	$4.17B	$1.86B	(m)	(m)	(m)	$1.60B	(m)	(m)	(m)	2.60×
2012-09-30	$2.52B	(m)	$4.30B	$1.78B	(m)	(m)	(m)	$3.23B	(m)	(m)	(m)	1.33×
2012-06-30	$2.84B	(m)	$4.52B	$1.69B	(m)	(m)	(m)	$2.93B	(m)	(m)	(m)	1.55×
2012-03-31	$2.13B	(m)	$3.81B	$1.69B	(m)	(m)	(m)	$2.77B	(m)	(m)	(m)	1.38×
2011-12-31	$2.25B	(m)	$3.93B	$1.68B	(m)	(m)	(m)	$2.46B	(m)	(m)	(m)	1.60×
2011-09-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-06-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-03-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	$1.76B	(m)	$3.08B	$1.32B	(m)	(m)	(m)	$1.21B	(m)	(m)	(m)	2.56×
2010-09-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-06-30	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-03-31	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2009-12-31	$1.43B	(m)	$2.75B	$1.32B	(m)	(m)	(m)	$1.05B	(m)	(m)	(m)	2.61×

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
TENET HEALTHCARE CORP (THC)	United States	$20.097B
Surgery Partners, Inc. (SGRY)	United States	$1.860B	-24.80
Ardent Health, Inc. (ARDT)	United States	$1.478B	17.91
COMMUNITY HEALTH SYSTEMS INC (CYH)	United States	$0.405B	1.87